These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7611607)

  • 1. Diabetes mellitus and interferon-alpha therapy.
    Murakami M; Iriuchijima T; Mori M
    Ann Intern Med; 1995 Aug; 123(4):318. PubMed ID: 7611607
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
    Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R
    Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone.
    Sato Y; Yasui-Furukori N; Kaneko S; Moriyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):577-8. PubMed ID: 17919798
    [No Abstract]   [Full Text] [Related]  

  • 6. [Augmentation of the immune response to islet cell antigens with development of diabetes mellitus caused by interferon-alpha therapy in chronic hepatitis C].
    Seifarth C; Benninger J; Böhm BO; Wiest-Ladenburger U; Hahn EG; Hensen J
    Z Gastroenterol; 1999 Mar; 37(3):235-9. PubMed ID: 10234796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
    J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of severe diabetic keto-acidosis with shock after changing interferon-beta into interferon-alpha for chronic hepatitis C.
    Hayakawa M; Gando S; Morimoto Y; Kemmotsu O
    Intensive Care Med; 2000 Jul; 26(7):1008. PubMed ID: 10990121
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant.
    Keshavarz R; Mousavi MA; Hassani C
    Pediatr Emerg Care; 2002 Feb; 18(1):22-4. PubMed ID: 11862133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
    Skomra S; Przybylska T
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmune diabetes after treatment with interferon-alpha].
    Mathieu E; Fain O; Sitbon M; Thomas M
    Presse Med; 1995 Jan; 24(4):238. PubMed ID: 7899374
    [No Abstract]   [Full Text] [Related]  

  • 13. Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α.
    Dasgupta A; Tsay E; Federman N; Lechner MG; Su MA
    Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35274131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin-dependent diabetes mellitus induced by interferon-alpha].
    Giuntoli P; Mariani S; Avoli D; Giammarco V
    Minerva Endocrinol; 1995 Dec; 20(4):243-5. PubMed ID: 8709922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
    Popescu C; Popescu GA; Arama V
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):101-4. PubMed ID: 23539399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis.
    Fabris P; Betterle C; Floreani A; Greggio NA; de Lazzari F; Naccarato R; Chiaramonte M
    Lancet; 1992 Aug; 340(8818):548. PubMed ID: 1354296
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interferon-alpha and development of type 1 diabetes].
    Pinés Corrales PJ; Aragón Valera C; Sanchón Rodríguez R; Ugidos de la Varga L
    Med Clin (Barc); 2005 Sep; 125(7):278-9. PubMed ID: 16137490
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of reversible diabetes mellitus after cessation of interferon-alpha therapy for chronic hepatitis C infection.
    Tasi TN; Hsieh CH
    N Z Med J; 2004 Dec; 117(1207):U1230. PubMed ID: 15608817
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acido-ketotic acute diabetes in a child treated by L-asparaginase].
    Aussannaire M; Cabanes J; Chaussain JL; Maria J
    Arch Fr Pediatr; 1972 May; 29(5):527-32. PubMed ID: 4632230
    [No Abstract]   [Full Text] [Related]  

  • 20. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.